PHARMARESEARCH BIO Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2014	FY 2014
Period Ending	Dec '14 Dec 31, 2014	Mar '14 Mar 31, 2014
Revenue	178.19	321.18
Revenue Growth (YoY)	-44.52%	-
Cost of Revenue	16.83	18.41
Gross Profit	161.36	302.77
Selling, General & Admin	823.15	430.09
Research & Development	83.03	71.44
Other Operating Expenses	10.23	9.45
Operating Expenses	921.11	514.16
Operating Income	-759.75	-211.4
Interest Expense	-122.85	-38.8
Interest & Investment Income	0.99	0.01
Currency Exchange Gain (Loss)	-	0.19
Other Non Operating Income (Expenses)	-1.9	4.58
EBT Excluding Unusual Items	-883.52	-245.41
Asset Writedown	-	-1
Pretax Income	-883.52	-246.41
Net Income	-883.52	-246.41
Net Income to Common	-883.52	-246.41
Shares Outstanding (Basic)	0	0
Shares Outstanding (Diluted)	0	0
Shares Change (YoY)	-0.00%	-
EPS (Basic)	-22088.06	-6160.12
EPS (Diluted)	-22088.06	-6160.12
Free Cash Flow	-415.75	-251.99
Free Cash Flow Per Share	-10393.76	-6299.54
Gross Margin	90.55%	94.27%
Operating Margin	-426.37%	-65.82%
Profit Margin	-495.83%	-76.72%
Free Cash Flow Margin	-233.32%	-78.46%
EBITDA	-755.07	-208.21
EBITDA Margin	-	-64.83%
D&A For EBITDA	4.69	3.19
EBIT	-759.75	-211.4
EBIT Margin	-	-65.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.